Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.
Sean Williams, The Motley Fool, The Motley Fool
Fri, 12/19/2014 - 5:10am
Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.